The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO GI 2026 | Pancreatic cancer highlights from ASCO GI 2026
Teresa Macarulla, MD, Vall d’Hebron University Hospital, Barcelona, Spain, highlights key takeaways in pancreatic cancer from the ASCO 2026 Gastrointestinal Cancers Symposium, including a novel KRAS G12D inhibitor shared in an oral presentation at the meeting. This interview took place at the 2026 American Society of Clinical Oncology Gastrointestinal Cancers Symposium in San Francisco, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
